| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Apr―01 |
Review article: Telecare in gastroenterology-Within the COVID-19 pandemic and beyond |
Fatima Hakak, Rajan N. Patel, Richard B. Gearry |
| 2 |
[GO] |
2023―Sep―05 |
Letter: ACE2, IBD and COVID-19-why IBD patients may be at reduced risk of COVID-19 |
Ralley E. Prentice, Doug Tjandra, Mayur Garg, John S. Lubel, Spiros Fourlanos, Doug Johnson, Aysha Al-Ani, Britt Christensen |
| 3 |
[GO] |
2023―Sep―05 |
Letter: Covid-19-re-initiating clinical services for chronic gastrointestinal diseases. How and when? Authors' reply |
Ralley E. Prentice, Aysha H. Al-Ani, Britt Christensen |
| 4 |
[GO] |
2023―Sep―05 |
Letter: Covid-19-re-initiating clinical services for chronic gastrointestinal diseases. How and when? |
Edward Britton, Paul Richardson, Ibrahim Mian, Thomas Conley, David Byrne, Holly Boyd, Connor Doherty, Sandipika Gupta, Sundas Butt, Sreedhar Subramanian |
| 5 |
[GO] |
2023―Sep―04 |
Letter: unknown denominator and misleading conclusions in COVID-19 |
Manuel Rodríguez-Perálvarez, Magdalena Salcedo, José Antonio Pons, Jordi Colmenero |
| 6 |
[GO] |
2023―Sep―04 |
Letter: gastrointestinal symptoms pre-admission are associated with greater severity of COVID-19 |
Jiong Yu, Weiming Xu, Jing Ma, Xinyu Sheng, Xiaowei Shi, Jian Wu, Qiaoling Pan, Jinfeng Yang, Hongcui Cao, Lanjuan Li |
| 7 |
[GO] |
2023―Sep―04 |
Editorial: intended victim or innocent bystander? The liver in COVID-19 |
Greg Packer, Mansoor N. Bangash |
| 8 |
[GO] |
2023―Sep―04 |
Letter: elevated liver enzymes and outcome in COVID-19 |
Anshuman Elhence, Ramesh Kumar |
| 9 |
[GO] |
2023―Sep―04 |
Letter: population mortality from COVID-19 and latitude-data from China. Authors' reply |
Jonathan M Rhodes, Sreedhar Subramanian, Eamon Laird, Rose Anne Kenny |
| 10 |
[GO] |
2023―Sep―04 |
Letter: severe COVID-19 infection and biologic therapies-a cohort study of 7 808 patients in France |
Pauline Bataille, Aurélien Amiot, Pascal Claudepierre, Nicolas Paris, Antoine Neuraz, Ivan Lerner, Nicolas Garcelon, Bastien Rance, Olivier Grisel, Thomas Moreau, Melodie Bernaux, Etienne Audureau, Emilie Sbidian |
| 11 |
[GO] |
2023―Sep―04 |
Letter: severe COVID-19 infection and biologic therapies-a cohort study of 7808 patients in France. Authors' reply |
Carlos Taxonera, Cristina Alba |
| 12 |
[GO] |
2023―Sep―04 |
Letter: liver involvement and mortality in COVID-19 patients |
Xiu-He Lv, Jin-Lin Yang, Kai Deng |
| 13 |
[GO] |
2023―Sep―04 |
Letter: liver involvement and mortality in COVID-19 patients - authors' reply |
Francesca Romana Ponziani, Fabio Del Zompo, Antonio Nesci, Francesco Santopaolo, Gianluca Ianiro, Antonio Gasbarrini, Maurizio Pompili |
| 14 |
[GO] |
2023―Sep―04 |
Editorial: intended victim or innocent bystander? The liver in COVID-19-Authors' reply |
Haijun Huang, Shanshan Chen, Hong Li, Xian-Long Zhou, Yining Dai, Jia Wu, Jun Zhang, Lina Shao, Rong Yan, Mingshan Wang, Jiafeng Wang, Yuexing Tu, Minghua Ge |
| 15 |
[GO] |
2023―Sep―04 |
Letter: gastrointestinal symptoms pre-admission are associated with greater severity of COVID-19-authors' reply |
Yuan Tian, Long Rong |
| 16 |
[GO] |
2023―Sep―04 |
Letter: unknown denominator and misleading conclusions in Covid-19-authors' reply |
Isabel Garrido, Rodrigo Liberal, Guilherme Macedo |
| 17 |
[GO] |
2023―Sep―04 |
Letter: SARS-CoV-2 induced gastrointestinal inflammation-authors' reply |
Carlos Taxonera, Cristina Alba |
| 18 |
[GO] |
2023―Sep―04 |
Letter: SARS-CoV-2-induced gastrointestinal inflammation |
Philipp A. Reuken, Michaela Wüst, Bettina Löffler, Michael Bauer, Andreas Stallmach |
| 19 |
[GO] |
2023―Sep―02 |
Letter: how frequently does COVID-19 mimic an IBD flare when community transmission of SARS-CoV-2 is active? |
Neil O’Morain, Carolann Coe, Patrick Mallon, Patrick Twomey, Cillian F. De Gascun, Glen A. Doherty |
| 20 |
[GO] |
2023―Sep―02 |
Letter: liver involvement and mortality in COVID-19-the role of anti-viral therapy should be considered |
Lucio Boglione, Roberto Rostagno, Federica Poletti, Roberta Moglia, Bianca Bianchi, Maria Esposito, Stefano Biffi, Silvio Borrè |
| 21 |
[GO] |
2023―Sep―02 |
Letter: SARS-CoV-2 infection in two IBD patients treated with dual targeted therapy |
Giuseppe Privitera, Daniela Pugliese, Franco Scaldaferri, Alessandro Armuzzi |
| 22 |
[GO] |
2023―Sep―02 |
Letter: SARS-CoV-2 infection in two inflammatory bowel disease patients treated with dual targeted therapy-Authors' reply |
Aysha H. Al-Ani, Ralley E. Prentice, Clarissa Rentsch, Britt Christensen |
| 23 |
[GO] |
2023―Sep―01 |
Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study |
Christopher A. Lamb, Shaji Sebastian, Alexandra J. Kent, Jonathan P. Segal, Haidee A. Gonzalez, Matthew J. Brookes, Shameer J. Mehta, Sreedhar Subramanian, Neeraj Bhala, Lucy C. Hicks, Thomas E. Conley, Kamal V. Patel, Gareth J. Walker, Nicholas A. Kennedy |
| 24 |
[GO] |
2023―Aug―12 |
STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease |
Simon Woelfel, Joel Dütschler, Marius König, Alex Dulovic, Nicole Graf, Daniel Junker, Vasileios Oikonomou, Claudia Krieger, Samuel Truniger, Annett Franke, Annika Eckhold, Kristina Forsch, Seraina Koller, Jacqueline Wyss, Niklas Krupka, Melanie Oberholzer, Nicola Frei, Nora Geissler, Peter Schaub, Werner C. Albrich, Matthias Friedrich, Nicole Schneiderhan-Marra, Benjamin Misselwitz, Wolfgang Korte, Justus J. Bürgi, Stephan Brand |
| 25 |
[GO] |
2023―Jun―25 |
Editorial: Alcohol-related liver disease is the primary driver of cirrhosis-related hospital admissions in the COVID-19 era-What can be done? |
Alexandra D. Frolkis, Stephen E. Congly |
| 26 |
[GO] |
2023―May―16 |
Trends in aetiology-based hospitalisation for cirrhosis before and during the
COVID
-19 pandemic in the United States |
Donghee Kim, Brandon J. Perumpail, Karn Wijarnpreecha, Richie Manikat, George Cholankeril, Aijaz Ahmed |
| 27 |
[GO] |
2023―Jan―16 |
Risk of severe and opportunistic infections and the impact of SARS-COV-2 on this risk in a nationwide cohort of patients with inflammatory bowel disease |
Nabeel Khan, Nadim Mahmud, Manthankumar Patel, Ramaswamy Sundararajan, Walter Reinisch |
| 28 |
[GO] |
2022―Dec―08 |
Editorial: immunosuppression and
SARS-CoV
-2 vaccination-where do we stand? |
Ashwin N. Ananthakrishnan |
| 29 |
[GO] |
2022―Oct―29 |
Systemic and T cell-associated responses to
SARS-CoV
-2 immunisation in gut inflammation (
STAR SIGN
study): effects of biologics on vaccination efficacy of the third dose of
mRNA
vaccines against
SARS-CoV
-2 |
Simon Woelfel, Joel Dütschler, Marius König, Nicole Graf, Vasileios Oikonomou, Claudia Krieger, Samuel Truniger, Annett Franke, Annika Eckhold, Kristina Forsch, Jacqueline Wyss, Niklas Krupka, Werner Albrich, Nicola Frei, Nora Geissler, Peter Schaub, Matthias Friedrich, Benjamin Misselwitz, Wolfgang Korte, Justus J. Bürgi, Stephan Brand |
| 30 |
[GO] |
2022―Oct―05 |
Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early
COVID
-19 pandemic: the
PREPARE-IBD
multicentre cohort study |
Aamir Saifuddin, Alexandra J. Kent, Shameer J. Mehta, Lucy C. Hicks, Haidee A. Gonzalez, Jonathan P. Segal, Matthew J. Brookes, Sreedhar Subramanian, Neeraj Bhala, Thomas E. Conley, Kamal V. Patel, Christopher A. Lamb, Gareth J. Walker, Nicholas A. Kennedy, Shaji Sebastian, Shukri Abdale, Abdulla Abbesi, Anwar Abusrewil, Precious Aghimien, Saeed Ahmed, Akram Ali, Amjad Ali, Jad Alkhouri, Patrick Allen, Ammar Al-Rifaie, Richard Appleby, Ramesh Arasaradnam, Naila Arebi, Bradley Arms-Williams, Muteeb Ashraf, Au Andrea, Tamar Avades, Homira Ayubi, Samantha Baillie, Sharmili Balarajah, Aaron Bancil, Abdul Basit, Murad Bayati, Andrew Bell, Alexander Berry, Neeraj Bhala, Shivaram Bhat, Joya Bhattacharyya, Sophia Bishop, Laura Blackmore, Ashley Bond, Simon Borg-Bartolo, Emma Botwright, Sonia Bouri, Stephen Boyle, Neil Bradley, Fiona Brailsford, Ewen Brennan, Deborah Britton, Matthew Brooks, Caitlin Brown, Rhys Butcher, Jeff Butterworth, Rachel Campbell, Roisin Campbell, Iona Campbell, Ruth Carr, Josiah Carter, Peter Cartlidge, Rajiv Chandy, Kelly Chatten, Rakesh Chaudhary, Desmond Chee, Jonathan Chessbrough, Andrea Churchhouse, Jennie Clough, Alexander Cole, Thomas Conley, Johannah Cook, Rachel Cooney, Sarah Cotton, Tamsin Critchlow, Frederic Cuison, Chris Curran, Ana-Marie Darie, Robin Dart, Pantong Davwar, Kasamu Kabiru Dawa, Anjan Dhar, Shahida Din, Kok Leong Diong, Benjamin Disney, Emma Dooks, Louise Downey, Anita D’Souza, Lovesh Dyall, Mary Elias, Richard Felwick, Michael Finegan, Paul Flanagan, Rishi Fofaria, Steven Fong, Richard Fox, Aileen Fraser, Christian Frunza, Alhasssan Ghodeif, Nivedita Ghosh, Leah Gilroy, Haidee Aleman Gonzalez, Larissa Good, John Gordon, Nicola Grasso, Aurelian Gueroult, James Gulliver, Sarah Guthrie, Markus Gwiggner, Mina Hanna, Christopher Harlow, Wendy Harrison, Ailsa Hart, Barney Hawthorne, Lucy Hicks, Patrick Hooper, Willow Howard, Nassir Hussain, Thomas Hutton, Aye Mya Htun, Peter Irving, Reema Jagdish, Anun Javed, Asima Javed, Nishani Jayasooriya, Matthew Johnson, Emma Johnston, Gareth-Rhys Jones, Cynthia Kanagasundaram, Foteini Karagkouni, Karen Kemp, Nick Kennedy, Alexandra Kent, Hesham Khalil, Najeebullah Khan, Zahid Khan, Mais Khasawneh, Andy King, Beverley Kirkham, Fiona Kirkham, Flora Kokwaro, Mohammed Korani, Ioannis Koumoutsos, Aditi Kumar, Anish John Kuriakose Kuzhiyanjal, Martyn Lakeland, Christopher Lamb, Sophie Laverick, Charlie Lees, Emma Levell, Scott Levison, Samuel Lim, Yuen-Hui Lim, Jimmy Limdi, James Lindsay, Jessica Lisle, Alan Lobo, Raphael Luber, Laura Lucacui, Holly Lyne, Jonathan MacDonald, Aarani Mahalingam, Sara Mahgoub, Ridhima Malakar, Fenella Marley, Joy Mason, Ali Masri, Zia Mazhar, Hannah McCaughan, Tracy McCort, Adam McCulloch, Stuart McIlwaine, Nirmol Meah, Leila Mebarek, Shameer Mehta, Mike Mendall, Nassir Mir, Victoria Moffatt, Gordon Moran, Liam Morris, Gary Morrison, Graham Morrison, Robert Mulligan, Charles Murray, Jenny Murray, Sally Myers, Pineshwari Naeck-Boolauky, Andres Naranjo, Janu Navaratnam, Deanna Naylor, Emma Nixon, Kirsty Nixon, Jonathan Nolan, Olaolu Olabintan, Elaine Ong Ming San, Hayley Owen, Christopher Palmer-Jones, Kamal Patel, Kalyan Peddada, Leon Pee, Mohammed Peerally, Rebecca Perkins, Frank Phillips, Keith Pohl, Richard Pollok, Nick Powell, Farah Qayyum, Maria Quarashi, Mohammed Nabil Quraishi, Elizabeth Radcliffe, Shellie Radford, Sohail Rahmany, Hanin Ramadan, Arvind Ramadas, Anne Reddington, Christy Riggott, Tom Riley, Peter Rimmer, Susan Ritchie, Konstantina Rosiou, Siobhan Rowland, Joseph Sabine, Aamir Saifuddin, Shahzad Sarwar, Ayodele Sasegbon, Jayne Saunders, Shaji Sebastian, Gregory Sebepos-Rogers, John Paul Seenan, Jonathan Segal, Christian Selinger, Solange Serna, Sonika Sethi, Matthew Shale, Richard Shenderey, Achuth Shenoy, Yousuf Sherifat, Roosy Sheth, Spyros Siakavellas, Rafid Sikafi, Amar Singh, Salil Singh, Updesh Singh, Ganesh Sivaji, Philip Smith, Ally Speight, Andy Spence, Cath Stansfield, Helen Steed, Sreedhar Subramanian, Kishaani Suseehran, Maria Tabuso, Donatas Taucius, Joanne Taylor, Amit Thakor, Tony Tham, Gill Townsend, Tristan Townsend, Thomas Troth, Ruth Tunney, Kelly Turner, Nosheen Umar, Vithushan Vakeeswarasarma, Ajay Verma, Gareth Walker, Hazel Wallace, Hannah Walton, Bo Wang, Eleanor Warner, Callum Watson, Susie Wen, Monika Widlak, Maureen Williams, Amy Woods, Lisa Younge, Mansoor Zafar |
| 31 |
[GO] |
2022―Jun―11 |
Letter: paying attention to the comorbidities or extraintestinal complications in patients with inflammatory bowel disease during the
COVID
-19 pandemic-authors’ reply |
Yousaf Hadi, Gursimran S. Kochhar |
| 32 |
[GO] |
2022―May―11 |
Letter: paying attention to the comorbidities or extraintestinal complications in patients with inflammatory bowel disease during the
COVID
-19 pandemic |
Wen-Qiang Yuan, Fei Li, Liu-Chan Yang, Zai-Li Yang, De-Jun Cui |
| 33 |
[GO] |
2022―Apr―16 |
Letter: association between COVID-19 and inflammatory bowel disease |
Hui-Yuan Chen, Shiow-Ing Wang, Renin Chang, James Cheng-Chung Wei |
| 34 |
[GO] |
2022―Apr―01 |
Letter: inflammatory bowel disease services during the Covid-19 pandemic |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
| 35 |
[GO] |
2022―Apr―01 |
Letter: inflammatory bowel disease services during the Covid-19 pandemic - authors' reply |
Mohammed Deputy, Ailsa Hart, Omar Faiz |
| 36 |
[GO] |
2022―Mar―31 |
Effectiveness and safety of SARS-CoV-2 vaccine in Inflammatory Bowel Disease patients: A systematic review, meta-analysis and meta-regression |
Abhishek Bhurwal, Hemant Mutneja, Vikas Bansal, Akshay Goel, Shilpa Arora, Bashar Attar, Carlos D. Minacapelli, Gursimran Kochhar, Lea Ann Chen, Steve Brant, Darren Seril |
| 37 |
[GO] |
2022―Feb―08 |
The use of, and outcomes for, inflammatory bowel disease services during the Covid-19 pandemic: a nationwide observational study |
Mohammed Deputy, Kapil Sahnan, Guy Worley, Komal Patel, Violeta Balinskaite, Alex Bottle, Paul Aylin, Elaine M Burns, Ailsa Hart, Omar Faiz |
| 38 |
[GO] |
2021―Dec―14 |
Incidence, outcomes, and impact of COVID-19 on inflammatory bowel disease: Propensity matched research network analysis |
Yousaf Hadi, Parambir S. Dulai, Justin Kupec, Nabeeha Mohy-Ud-Din, Vipul Jairath, Francis A. Farraye, Gursimran S. Kochhar |
| 39 |
[GO] |
2021―Dec―09 |
Systematic review with meta-analysis: COVID-19 outcomes in patients receiving anti-TNF treatments |
Georgios Kokkotis, Konstantina Kitsou, Ioannis Xynogalas, Vana Spoulou, Gkikas Magiorkinis, Ioannis Trontzas, Panagiotis Trontzas, Garyphallia Poulakou, Konstantinos Syrigos, Giorgos Bamias |
| 40 |
[GO] |
2021―Oct―25 |
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study |
Cristina Bezzio, Alessandro Armuzzi, Federica Furfaro, Sandro Ardizzone, Monica Milla, Sonia Carparelli, Ambrogio Orlando, Flavio Andrea Caprioli, Fabiana Castiglione, Chiara Viganò, Davide Giuseppe Ribaldone, Fabiana Zingone, Rita Monterubbianesi, Nicola Imperatore, Stefano Festa, Marco Daperno, Ludovica Scucchi, Antonio Ferronato, Luca Pastorelli, Paola Balestrieri, Chiara Ricci, Maria Cappello, Carla Felice, Gionata Fiorino, Simone Saibeni, Francesca Coppini, Patrizia Alvisi, Viviana Gerardi, Angela Variola, Silvia Mazzuoli, Marco Vincenzo Lenti, Daniela Pugliese, Mariangela Allocca, Francesca Ferretti, Jenny Roselli, Fabrizio Bossa, Alessandra Giuliano, Nicole Piazza, Gianpiero Manes, Alessandro Sartini, Andrea Buda, Federica Micheli, Valeria Ciardo, Giovanni Casella, Angelo Viscido, Giorgia Bodini, Valentina Casini, Alessandra Soriano, Arnaldo Amato, Laurino Grossi, Sara Onali, Matteo Rottoli, Rocco Spagnuolo, Stefania Baroni, Claudio Camillo Cortelezzi, Monia Baldoni, Marta Vernero, Franco Scaldaferri, Giovanni Maconi, Alessia Dalila Guarino, Andrea Palermo, Renata D’Incà, Maria Lia Scribano, Livia Biancone, Lucio Carrozza, Marta Ascolani, Francesco Costa, Antonio Di Sabatino, Irene Zammarchi, Matteo Gottin, Francesco Simone Conforti |
| 41 |
[GO] |
2021―Sep―26 |
Letter: the BSG COVID-19 interim coeliac disease guidance no-biopsy approach is safe in adults |
Lina Bourhan Tashtoush, Nicholas Charles Bosanko, Samuel Robin Broad, Ying Jenny Chan, Natasha Singhal, Sharon Saji, Nissy Saju, Anusha Shah, Ansab Zulfiqar, Melina Ilarionos, Siba Prosad Paul |
| 42 |
[GO] |
2021―Sep―02 |
Review Article: Vaccination for patients with inflammatory bowel disease during the COVID-19 pandemic |
Jayne Doherty, Sean Fennessy, Roisin Stack, Neil O’ Morain, Garret Cullen, Elizabeth J. Ryan, Cillian De Gascun, Glen A. Doherty |
| 43 |
[GO] |
2021―Jun―25 |
Editorial: IBD medications during the COVID-19 pandemic-are they safe to use? |
Dali Fan, Richard B. Gearry |
| 44 |
[GO] |
2021―Jun―10 |
Risk of severe COVID-19 in patients treated with IBD medications: a French nationwide study |
Antoine Meyer, Laura Semenzato, Mahmoud Zureik, Alain Weill, Franck Carbonnel, Rosemary Dray-Spira |
| 45 |
[GO] |
2020―Oct―07 |
Letter: population mortality from COVID-19 and latitude-data from China |
Nanyang Liu, Hao Li |
| 46 |
[GO] |
2020―Aug―31 |
Systematic review with meta-analysis: SARS-CoV-2 stool testing and the potential for faecal-oral transmission |
Amarylle S. van Doorn, Berrie Meijer, Chris M. A. Frampton, Murray L. Barclay, Nanne K. H. de Boer |
| 47 |
[GO] |
2020―Aug―15 |
Letter: prevalence and patterns of gastrointestinal symptoms in a large Western cohort of patients with COVID-19 |
Gianluca Ianiro, Serena Porcari, Carlo Romano Settanni, Stefano Bibbò, Francesca Romana Ponziani, Lorenzo Zileri dal Verme, Francesco Franceschi, Giovanni Cammarota, Antonio Gasbarrini |
| 48 |
[GO] |
2020―Aug―15 |
Letter: online search trends suggest patient concerns around immunosuppression use in inflammatory bowel disease during COVID-19 in the United Kingdom |
Mohammed Nabil Quraishi, Jonathan P. Segal, Rachel Cooney, Nicholas A. Kennedy, Rachel Ainley, Naveen Sharma, Neeraj B. Bhala, Matthew J. Brookes |
| 49 |
[GO] |
2020―Aug―15 |
Letter: role of probiotics in the COVID-19 pandemic |
Enrik John T. Aguila, Marie Antoinette D. C. Lontok, Eliezer James T. Aguila |
| 50 |
[GO] |
2020―Aug―15 |
Letter: role of probiotics in the COVID-19 pandemic-authors' reply |
Yuan Tian, Long Rong |
| 51 |
[GO] |
2020―Aug―15 |
Letter: is pneumococcal vaccination safe during the COVID-19 pandemic? |
Rabia Deniz, Arif Atahan Çağatay, Ahmet Gül |
| 52 |
[GO] |
2020―Aug―15 |
Letter: is pneumococcal vaccination safe during the COVID-19 pandemic? Authors’ reply |
Aysha H. Al-Ani, Doug Johnson, Britt Christensen |
| 53 |
[GO] |
2020―Aug―15 |
Letter: prevalence and patterns of gastrointestinal symptoms in a large Western cohort of patients with coronavirus disease 2019-authors' reply |
Yuan Tian, Long Rong |
| 54 |
[GO] |
2020―Aug―15 |
Letter: immunotherapy in IBD patients in a SARS-CoV-2 endemic area |
Constanze H. Waggershauser, Cornelia Tillack-Schreiber, Christine Berchtold-Benchieb, Daniel Szokodi, Stefanie Howaldt, Thomas Ochsenkühn |
| 55 |
[GO] |
2020―Aug―15 |
Letter: immunotherapy for IBD patients in a SARS-CoV-2 endemic area-authors' reply |
Carlos Taxonera, Iñigo Sagastagoitia, Cristina Alba |
| 56 |
[GO] |
2020―Aug―10 |
Editorial: social distancing during the COVID-19 pandemic - IBD patients cannot stay at home forever |
Samantha Jane Benson-Pope, Richard B. Gearry |
| 57 |
[GO] |
2020―Aug―10 |
Editorial: social distancing during the COVID-19 pandemic-IBD patients cannot stay at home forever. Authors' reply |
Carlos Taxonera, Cristina Alba |
| 58 |
[GO] |
2020―Aug―10 |
Letter: IBD nurse-a pivotal role in the time of the pandemic |
Muhammad Umair Khan, Kamran Mushtaq, Khalid Mohsin A. A. Al-Ejji, Rafie A. Yakoob, Saad Rashid Alkaabi, Masoud Khoshnia |
| 59 |
[GO] |
2020―Aug―10 |
Letter: IBD nurse-pivotal role in the time of the pandemic. Authors’ reply |
Aysha H. Al-Ani, Clarissa A. Rentsch, Sofia Azim, Emma Bidgood, Princy Onasseril, Britt Christensen |
| 60 |
[GO] |
2020―Jul―22 |
The association between markers of liver injury and clinical outcomes in patients with COVID-19 in Wuhan |
Haijun Huang, Shanshan Chen, Hong Li, Xian-Long Zhou, Yining Dai, Wu Jia, Jun Zhang, Lina Shao, Rong Yan, Mingshan Wang, Jiafeng Wang, Yuexing Tu, Minghua Ge |
| 61 |
[GO] |
2020―Jul―13 |
Letter: ACE2, Rho kinase inhibition and the potential role of vitamin D against COVID-19 |
Giovanni Bertoldi, Lisa Gianesello, Lorenzo A. Calò |
| 62 |
[GO] |
2020―Jul―13 |
Letter: liver disease and COVID-19-not the perfect storm |
Rooshi Nathwani, Sujit Mukherjee, Roberta Forlano, Benjamin H. Mullish, Nikhil Vergis, Nowlan Selvapatt, Pinelopi Manousou, Shevanthi Nayagam, Maud Lemoine, Ameet Dhar |
| 63 |
[GO] |
2020―Jul―13 |
Letter: liver disease and COVID-19-not the perfect storm. Authors' reply” |
Isabel Garrido, Rodrigo Liberal, Guilherme Macedo |
| 64 |
[GO] |
2020―Jul―08 |
Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19 |
Anand V. Kulkarni, Pramod Kumar, Harsh Vardhan Tevethia, Madhumita Premkumar, Juan Pablo Arab, Roberto Candia, Rupjyoti Talukdar, Mithun Sharma, Xiaolong Qi, Padaki Nagaraja Rao, Duvvuru Nageshwar Reddy |
| 65 |
[GO] |
2020―Jul―06 |
Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2 positive patients |
Francesca Romana Ponziani, Fabio Del Zompo, Antonio Nesci, Francesco Santopaolo, Gianluca Ianiro, Maurizio Pompili, Antonio Gasbarrini |
| 66 |
[GO] |
2020―Jun―25 |
Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2-exploring RAS inhibitors-authors’ reply |
Carlos Taxonera, Iñigo Sagastagoitia, Cristina Alba, Norberto Mañas, David Olivares, Enrique Rey |
| 67 |
[GO] |
2020―May―20 |
Letter: does vitamin D have a potential role against COVID-19? |
Deepak Kumar, Prakamya Gupta, Dibyajyoti Banerjee |
| 68 |
[GO] |
2020―May―14 |
“Review article: COVID-19 and liver disease - what we know on 1st May 2020” |
Isabel Garrido, Rodrigo Liberal, Guilherme Macedo |
| 69 |
[GO] |
2020―May―14 |
Letter: low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity |
Jose Mansur |
| 70 |
[GO] |
2020―May―14 |
Letter: low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity. Authors' reply |
Jonathan M Rhodes, Sreedhar Subramanian, Eamon Laird, Rose Anne Kenny |
| 71 |
[GO] |
2020―May―14 |
Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic |
Samantha Jane Benson-Pope, Richard B. Gearry |
| 72 |
[GO] |
2020―May―14 |
Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic-authors' reply |
Dominic Stephen King, Nigel John Trudgill, Nicola J. Adderley |
| 73 |
[GO] |
2020―May―14 |
Letter: does vitamin D have a potential role against COVID-19? Authors' reply |
Yuan Tian, Long Rong |
| 74 |
[GO] |
2020―May―06 |
Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2 - exploring RAS inhibitors |
Mayur Garg, Simon G Royce, John S Lubel |
| 75 |
[GO] |
2020―May―02 |
2019 Novel Coronavirus Disease (COVID-19) in patients with Inflammatory Bowel Diseases |
Carlos Taxonera, Iñigo Sagastagoitia, Cristina Alba, Norberto Mañas, David Olivares, Enrique Rey |
| 76 |
[GO] |
2020―Apr―30 |
Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North - supports vitamin D as a factor determining severity. Authors' reply |
Mayur Garg, Aysha Al-Ani, Hannah Mitchell, Philip Hendy, Britt Christensen |
| 77 |
[GO] |
2020―Apr―29 |
Review Article: Prevention, Diagnosis and Management of COVID-19 in the Inflammatory Bowel Disease Patient |
Aysha Al-Ani, Ralley Prentice, Clarissa Rentsch, Doug Johnson, Zaid Ardalan, Neel Heerasing, Mayur Garg, Sian Campbell, Joe Sasadeusz, Fin Macrae, Siew C. Ng, David T. Rubin, Britt Christensen |
| 78 |
[GO] |
2020―Apr―20 |
Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North - supports vitamin D as a factor determining severity |
Jonathan M Rhodes, Sreedhar Subramanian, Eamon Laird, Rose Anne Kenny |
| 79 |
[GO] |
2020―Apr―14 |
Letter: Covid-19 and vitamin D-authors' reply |
Yuan Tian, Long Rong |
| 80 |
[GO] |
2020―Apr―13 |
Letter: Covid-19, and vitamin D |
Alba Panarese, Endrit Shahini |
| 81 |
[GO] |
2020―Mar―29 |
Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission |
Yuan Tian, Long Rong, Weidong Nian, Yan He |
|
